Y-mAbs Therapeutics, Inc. Shareholders' Equity
Y-mAbs Therapeutics, Inc. had Shareholders' Equity of $87.49 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2025-08-08
- 2025-06-30: Stockholders' Equity Attributable to Parent $87.49M.
- 2025-03-31: Stockholders' Equity Attributable to Parent $89.46M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $92.00M.
- 2024-09-30: Stockholders' Equity Attributable to Parent $92.43M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-06-30 | $87.49M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $89.46M 10-Q · filed 2025-08-08 |
| 2024-12-31 | $92.00M 10-Q · filed 2025-08-08 |
| 2024-09-30 | $92.43M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $95.34M 10-Q · filed 2025-08-08 |
| 2024-03-31 | $99.19M 10-Q · filed 2025-08-08 |
| 2023-12-31 | $100.98M 10-Q · filed 2025-08-08 |
| 2023-09-30 | $100.15M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $104.68M 10-Q · filed 2024-11-08 |
| 2023-03-31 | $107.83M 10-Q · filed 2024-11-08 |
| 2022-12-31 | $109.22M 10-K · filed 2025-03-04 |
| 2022-09-30 | $107.90M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $131.40M 10-Q · filed 2023-11-13 |
| 2022-03-31 | $157.47M 10-Q · filed 2023-11-13 |
| 2021-12-31 | $180.11M 10-K · filed 2024-02-29 |
| 2021-09-30 | $210.84M 10-Q · filed 2022-11-07 |
| 2021-06-30 | $234.32M 10-Q · filed 2022-11-07 |
| 2021-03-31 | $252.22M 10-Q · filed 2022-11-07 |
| 2020-12-31 | $105.84M 10-K · filed 2023-03-30 |
| 2020-09-30 | $116.51M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $146.01M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $175.33M 10-Q · filed 2021-11-04 |
| 2019-12-31 | $198.90M 10-K · filed 2022-03-01 |
| 2019-09-30 | $85.94M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $108.38M 10-Q · filed 2020-11-05 |
| 2019-03-31 | $125.51M 10-Q · filed 2020-11-05 |
| 2018-12-31 | $140.53M 10-K · filed 2022-03-01 |
| 2018-09-30 | $155.03M 10-Q · filed 2019-11-13 |
| 2018-06-30 | $65.52M 10-Q · filed 2019-11-13 |
| 2018-03-31 | $74.84M 10-Q · filed 2019-11-13 |
| 2017-12-31 | $82.15M 10-K · filed 2020-03-12 |
| 2016-12-31 | $12.06M 10-K · filed 2019-03-22 |